Megan C Roberts1, Taylor Murphy1, Jennifer L Moss1, Christopher W Wheldon1, Wayne Psek1. 1. At the time of this work, Megan C. Roberts, Jennifer L. Moss, and Christopher W. Wheldon were with the National Cancer Institute, Rockville, MD. Taylor Murphy was with George Washington University, Washington, DC. Wayne Psek was with the Milken Institute School of Public Health, George Washington University.
Abstract
OBJECTIVES: To examine how combinations of state policies, rather than single policies, are related to uptake of human papillomavirus (HPV) vaccine. METHODS: Using publicly available records and the literature, we characterized policies for each US state and Washington, DC, in 2015 (n = 51), including (1) Medicaid expansion, (2) policies permitting HPV vaccination in pharmacies, (3) school-entry requirements, (4) classroom sex education mandates, and (5) parental education mandates. Using qualitative comparative analysis, we identified which existing combinations of these policies were necessary and sufficient for high HPV vaccine initiation among adolescents, with National Immunization Survey-Teen data. RESULTS: No single policy was necessary or sufficient for high HPV vaccine uptake; however, 1 set of policies had consistently high HPV vaccine uptake: adoption of all policies except parental education mandates (girls: consistency = 1.00, coverage = 0.07; boys: consistency = 0.99, coverage = 0.08). CONCLUSIONS: We identified a set of polices related to high HPV vaccine uptake. Future studies should examine how these policies and others, individually and in combination, are associated with HPV vaccine uptake. Public Health Implications. This study provides insight into what sets of policies are consistently related to high HPV vaccine uptake.
OBJECTIVES: To examine how combinations of state policies, rather than single policies, are related to uptake of human papillomavirus (HPV) vaccine. METHODS: Using publicly available records and the literature, we characterized policies for each US state and Washington, DC, in 2015 (n = 51), including (1) Medicaid expansion, (2) policies permitting HPV vaccination in pharmacies, (3) school-entry requirements, (4) classroom sex education mandates, and (5) parental education mandates. Using qualitative comparative analysis, we identified which existing combinations of these policies were necessary and sufficient for high HPV vaccine initiation among adolescents, with National Immunization Survey-Teen data. RESULTS: No single policy was necessary or sufficient for high HPV vaccine uptake; however, 1 set of policies had consistently high HPV vaccine uptake: adoption of all policies except parental education mandates (girls: consistency = 1.00, coverage = 0.07; boys: consistency = 0.99, coverage = 0.08). CONCLUSIONS: We identified a set of polices related to high HPV vaccine uptake. Future studies should examine how these policies and others, individually and in combination, are associated with HPV vaccine uptake. Public Health Implications. This study provides insight into what sets of policies are consistently related to high HPV vaccine uptake.
Authors: Charitha Gowda; Ruth C Carlos; Amy T Butchart; Dianne C Singer; Matthew M Davis; Sarah J Clark; Amanda F Dempsey Journal: Sex Transm Dis Date: 2012-06 Impact factor: 2.830
Authors: Julia M L Brotherton; Masha Fridman; Cathryn L May; Genevieve Chappell; A Marion Saville; Dorota M Gertig Journal: Lancet Date: 2011-06-18 Impact factor: 79.321
Authors: Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher Journal: Vaccine Date: 2012-04-03 Impact factor: 3.641
Authors: Stuart Cowburn; Matthew Carlson; Jodi Lapidus; John Heintzman; Steffani Bailey; Jennifer DeVoe Journal: Am J Public Health Date: 2014-07-17 Impact factor: 9.308
Authors: Harrell W Chesson; Donatus U Ekwueme; Mona Saraiya; Meg Watson; Douglas R Lowy; Lauri E Markowitz Journal: Vaccine Date: 2012-08-04 Impact factor: 3.641
Authors: Kimberley Kavanagh; Kevin G Pollock; Kate Cuschieri; Tim Palmer; Ross L Cameron; Cameron Watt; Ramya Bhatia; Catherine Moore; Heather Cubie; Margaret Cruickshank; Chris Robertson Journal: Lancet Infect Dis Date: 2017-09-28 Impact factor: 25.071
Authors: Erika L Thompson; Ellen M Daley; Tricia Washburn; Kim Salisbury-Keith; Debbie Saslow; Holly B Fontenot; Gregory D Zimet Journal: Hum Vaccin Immunother Date: 2020-12-17 Impact factor: 3.452
Authors: Page D Dobbs; Ginny Chadwick; Katherine W Ungar; Chris M Dunlap; Katherine A White; Michael Ct Kelly; Marshall K Cheney Journal: Tob Control Date: 2019-10-14 Impact factor: 7.552